{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T16:30:20Z","timestamp":1773851420052,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["No.2024AAC03511"],"award-info":[{"award-number":["No.2024AAC03511"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["No.2024AAC03511"],"award-info":[{"award-number":["No.2024AAC03511"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["No.2024AAC03511"],"award-info":[{"award-number":["No.2024AAC03511"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-026-04805-4","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:52:20Z","timestamp":1770904340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["FSTIV score is essential for clinical management and predicts outcome of idiopathic membranous nephropathy"],"prefix":"10.1186","volume":"27","author":[{"given":"Yonghua","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lirong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yali","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"key":"4805_CR1","doi-asserted-by":"crossref","unstructured":"Ronco P, Beck L, Debiec H, et al. Membranous nephropathy. Nat Reviews Disease Primers. 2021;7.","DOI":"10.1038\/s41572-021-00303-z"},{"key":"4805_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/01913123.2023.2236225","volume":"47","author":"G Stefan","year":"2023","unstructured":"Stefan G, Balcan GT, Petre N, et al. Anti-phospholipase A2 receptor positive membranous nephropathy: investigating the link between electron microscopy stages and clinical outcome. Ultrastruct Pathol. 2023;47:365\u201372.","journal-title":"Ultrastruct Pathol"},{"key":"4805_CR3","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/his.13955","volume":"75","author":"MJ Stangou","year":"2019","unstructured":"Stangou MJ, Marinaki S, Papachristou E, et al. Histological grading in primary membranous nephropathy is essential for clinical management and predicts outcome of patients. Histopathology. 2019;75:660\u201371.","journal-title":"Histopathology"},{"issue":"17","key":"4805_CR4","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.21037\/atm-20-1669","volume":"8","author":"J Dong","year":"2020","unstructured":"Dong J, Li Y, Yue S, et al. The profiles of biopsy-proven renal tubulointerstitial lesions in patients with glomerular disease. Ann Transl Med. 2020;8(17):1066.","journal-title":"Ann Transl Med"},{"issue":"1","key":"4805_CR5","doi-asserted-by":"publisher","first-page":"2501379","DOI":"10.1080\/0886022X.2025.2501379","volume":"47","author":"Y Liu","year":"2025","unstructured":"Liu Y, Ma X, Yu M, et al. Renal tubulointerstitial lesions: a prognostic marker in idiopathic membranous nephropathy. Ren Fail. 2025;47(1):2501379.","journal-title":"Ren Fail"},{"key":"4805_CR6","doi-asserted-by":"crossref","unstructured":"Cheng P, Xie Q, Liu S, Liu X, Wang L, Hao CM. Aggressive treatment may be needed for idiopathic membranous nephropathy with focal segmental glomerulosclerosis lesions. Rev Assoc Med Bras (1992). 2024;70(4):e20230871.","DOI":"10.1590\/1806-9282.20230871"},{"issue":"1","key":"4805_CR7","doi-asserted-by":"publisher","first-page":"2512052","DOI":"10.1080\/0886022X.2025.2512052","volume":"47","author":"S Xu","year":"2025","unstructured":"Xu S, Liu X, Chen X, Chen B, Lin S, You X, Li D, Zhang J, Chen C. Clinicopathological and prognostic study of idiopathic membranous nephropathy with tip or non-tip variant focal segmental glomerulosclerosis: a single-center cohort study. Ren Fail. 2025;47(1):2512052.","journal-title":"Ren Fail"},{"issue":"Pt 2","key":"4805_CR8","doi-asserted-by":"publisher","first-page":"113379","DOI":"10.1016\/j.intimp.2024.113379","volume":"143","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xie J, Lu M, et al. The outcomes of primary membranous nephropathy treated with cyclophosphamide are superior to calcineurin inhibitors in patients with renal vascular lesions: A multi-center retrospective cohort study. Int Immunopharmacol. 2024;143(Pt 2):113379.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4805_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s40620-014-0057-0","volume":"27","author":"Y Chen","year":"2014","unstructured":"Chen Y, Tang L, Feng Z, et al. Pathological predictors of renal outcomes in nephrotic idiopathic membranous nephropathy with decreased renal function. J Nephrol. 2014;27(3):307\u201316.","journal-title":"J Nephrol"},{"key":"4805_CR10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1053\/j.ajkd.2019.12.014","volume":"76","author":"MT Eadon","year":"2020","unstructured":"Eadon MT, Schwantes-An T-H, Phillips CL, et al. Kidney histopathology and prediction of kidney failure: A retrospective cohort study. Am J Kidney Dis. 2020;76:350\u201360.","journal-title":"Am J Kidney Dis"},{"key":"4805_CR11","doi-asserted-by":"crossref","unstructured":"Stevens PE, Ahmed SB, Carrero JJ, et al. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105:S117-S314.","DOI":"10.1016\/j.kint.2023.10.018"},{"key":"4805_CR12","doi-asserted-by":"crossref","unstructured":"Chung EYM, Wang YM, Keung K, et al. Membranous nephropathy: clearer pathology and mechanisms identify potential strategies for treatment. Front Immunol. 2022;13.","DOI":"10.3389\/fimmu.2022.1036249"},{"key":"4805_CR13","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1080\/0886022X.2018.1487864","volume":"40","author":"M Yamaguchi","year":"2018","unstructured":"Yamaguchi M, Ando M, Katsuno T, et al. Urinary protein and renal prognosis in idiopathic membranous nephropathy: a multicenter retrospective cohort study in Japan. Ren Fail. 2018;40:435\u201341.","journal-title":"Ren Fail"},{"key":"4805_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1159\/000339628","volume":"36","author":"B Sprangers","year":"2012","unstructured":"Sprangers B, Bomback AS, Cohen SD, et al. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center. Am J Nephrol. 2012;36:78\u201389.","journal-title":"Am J Nephrol"},{"key":"4805_CR15","doi-asserted-by":"crossref","unstructured":"Sun M, Li P, Dong J, et al. Clinical characteristics and prognosis of patients with idiopathic membranous nephropathy with kidney tubulointerstitial damage. Ren Fail. 2023;45.","DOI":"10.1080\/0886022X.2023.2205951"},{"key":"4805_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/nep.13691","volume":"25","author":"Z Xie","year":"2020","unstructured":"Xie Z, Dong W, Li Z, et al. Clinical value of renal phospholipase A2 receptor deposit in the prognosis evaluation and treatment options of idiopathic membranous nephropathy: A retrospective cohort study. Nephrology. 2020;25:219\u201329.","journal-title":"Nephrology"},{"key":"4805_CR17","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.prp.2012.08.004","volume":"208","author":"I Horvatic","year":"2012","unstructured":"Horvatic I, Ljubanovic DG, Bulimbasic S, et al. Prognostic significance of glomerular and tubulointerstitial morphometry in idiopathic membranous nephropathy. Pathol - Res Pract. 2012;208:662\u20137.","journal-title":"Pathol - Res Pract"},{"key":"4805_CR18","doi-asserted-by":"crossref","unstructured":"Zhang X-d, Cui Z, Zhang M-f, et al. Clinical implications of pathological features of primary membranous nephropathy. BMC Nephrol. 2018;19.","DOI":"10.1186\/s12882-018-1011-5"},{"key":"4805_CR19","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1681\/ASN.2017121260","volume":"29","author":"A Srivastava","year":"2018","unstructured":"Srivastava A, Palsson R, Kaze AD, et al. The prognostic value of histopathologic lesions in native kidney biopsy specimens: results from the Boston kidney biopsy cohort study. J Am Soc Nephrol. 2018;29:2213\u201324.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"4805_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s40620-024-01893-z","volume":"37","author":"W Ren","year":"2024","unstructured":"Ren W, Sun J, Zhang L, et al. Significance of the total renal chronicity score in predicting renal outcome in PLA2R-associated membranous nephropathy. J Nephrol. 2024;37(4):1051\u201361.","journal-title":"J Nephrol"},{"issue":"6","key":"4805_CR21","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2215\/CJN.11761116","volume":"12","author":"WG Couser","year":"2017","unstructured":"Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol. 2017;12(6):983\u201397.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4805_CR22","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.kint.2017.09.028","volume":"93","author":"MS Hommos","year":"2018","unstructured":"Hommos MS, Zeng C, Liu Z, et al. Global glomerulosclerosis with nephrotic syndrome; the clinical importance of age adjustment. Kidney Int. 2018;93:1175\u201382.","journal-title":"Kidney Int"},{"key":"4805_CR23","doi-asserted-by":"crossref","unstructured":"Lu W, Gong S, Li J, et al. Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension. Exp Ther Med. 2020.","DOI":"10.3892\/etm.2020.8506"},{"key":"4805_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2010111130","volume":"23","author":"K El Karoui","year":"2012","unstructured":"El Karoui K, Hill GS, Karras A, et al. A clinicopathologic study of thrombotic microangiopathy in IgA nephropathy. J Am Soc Nephrol. 2012;23:137\u201348.","journal-title":"J Am Soc Nephrol"},{"key":"4805_CR25","first-page":"257","volume":"36","author":"CQ Li Jingyi","year":"2020","unstructured":"Li Jingyi CQ, Shi Sufang L, Lijun Z, Xujie W, Suxia YX, LyuJicheng Z. Clinicopathological characteristics and prognosis of non-hypertensive IgA nephropathy patients with microangiopathy lesions. Chin J Nephrol. 2020;36:257\u201363.","journal-title":"Chin J Nephrol"},{"key":"4805_CR26","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/s41379-019-0259-z","volume":"32","author":"JS Chua","year":"2019","unstructured":"Chua JS, Zandbergen M, Wolterbeek R, et al. Complement-mediated microangiopathy in IgA nephropathy and IgA vasculitis with nephritis. Mod Pathol. 2019;32:1147\u201357.","journal-title":"Mod Pathol"},{"key":"4805_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/0886022X.2019.1605294","volume":"41","author":"X Chen","year":"2019","unstructured":"Chen X, Chen Y, Ding X, et al. Baseline proteinuria level is associated with prognosis in idiopathic membranous nephropathy. Ren Fail. 2019;41:363\u20139.","journal-title":"Ren Fail"},{"key":"4805_CR28","first-page":"487","volume-title":"New Understanding on the role of proteinuria in progression of chronic kidney disease","author":"D Liu","year":"2019","unstructured":"Liu D, Lv L-L. New Understanding on the role of proteinuria in progression of chronic kidney disease. Renal Fibrosis: Mechanisms and Therapies; 2019. pp. 487\u2013500."},{"key":"4805_CR29","doi-asserted-by":"crossref","unstructured":"Cheng W, Sun L, Dong H, et al. Clinicopathologic characteristic and prognosis in idiopathic membranous nephropathy patients with focal segmental sclerosis lesion. Medicine. 2021;100.","DOI":"10.1097\/MD.0000000000023988"},{"key":"4805_CR30","doi-asserted-by":"crossref","unstructured":"Guan M, Wu L, Cheng Y, et al. Defining the threshold: triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio\u2019s non-linear impact on tubular atrophy in primary membranous nephropathy. Front Endocrinol (Lausanne). 2024; 15.","DOI":"10.3389\/fendo.2024.1322646"},{"key":"4805_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/his.15115","volume":"84","author":"D Kipgen","year":"2023","unstructured":"Kipgen D, Crosby J, Dey V, et al. The relationship between histopathological features, immunosuppression and outcome in patients undergoing native kidney biopsies. Histopathology. 2023;84:671\u201382.","journal-title":"Histopathology"},{"key":"4805_CR32","doi-asserted-by":"crossref","unstructured":"Liang J, Hao W, Xia F, et al. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy. Ren Fail. 2023;45.","DOI":"10.1080\/0886022X.2023.2212081"},{"key":"4805_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000531693","volume":"54","author":"P Puapatanakul","year":"2023","unstructured":"Puapatanakul P, Banjongjit A, Kanjanabuch T, et al. Clinicopathological characteristics and impacts on clinical outcomes of thrombotic microangiopathy lesions in patients with Immunoglobulin A nephropathy in Thailand. Am J Nephrol. 2023;54:308\u201318.","journal-title":"Am J Nephrol"},{"issue":"4","key":"4805_CR34","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.kint.2017.01.002","volume":"91","author":"S Sethi","year":"2017","unstructured":"Sethi S, D\u2019Agati VD, Nast CC, et al. A proposal for standardized grading of chronic changes in native kidney biopsy specimens. Kidney Int. 2017;91(4):787\u20139.","journal-title":"Kidney Int"},{"issue":"2","key":"4805_CR35","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1093\/ndt\/gfy220","volume":"34","author":"S Sethi","year":"2019","unstructured":"Sethi S, Fervenza FC. Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transpl. 2019;34(2):193\u20139.","journal-title":"Nephrol Dial Transpl"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-04805-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04805-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-04805-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:18:15Z","timestamp":1773829095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-04805-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4805"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-04805-4","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"10 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the ethical standards of the Helsinki Declaration and its later amendments. People\u2019s Hospital of Ningxia Hui Autonomous Region had approval for the study protocol. Informed consent requirements were waived for the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}